Posts tagged as:

calcitonin gene-related peptide receptor antagonist

Telcagepant to be Sublingual

by James on 22 September 2010

On Monday the announcement came from Global Health Ventures, Inc., that they would be developing a sublingual version of migraine drug telcagepant. Telcagepant, a calcitonin gene-related peptide receptor antagonist, has had a rocky beginning.  Hailed in 2008 as the beginning of a new era in migraine treatment, the trials faltered over concerns about preventative use. [...]

{ 1 comment }

New Migraine Drug Telcagepant – Not Dead Yet

by James on 13 October 2009

The pharmaceutical company Merck & Co., Inc was at the 14th International Headache Congress in September, talking again about the migraine drug Telcagepant.  And hopes that Telcagepant will see the light of day aren’t dead yet. After concerns about using Telcagepant as a migraine preventative, Merck has moved ahead with trials using the new drug [...]

{ 4 comments }